Cai, T.; Palumbo, F.; Miacola, C.; Ceruti, C.; Rizzo, M.; Liguori, G.; Gallelli, L.; Palmieri, A., on behalf of the Italian Society of Andrology (SIA).
Icarifil® in Association with Daily Use of Tadalafil (5 mg) versus Standard Tadalafil Daily Dose (5 mg) or Alone: Results from a Controlled, Randomized Clinical Trial. J. Clin. Med. 2024, 13, 2564.
https://doi.org/10.3390/jcm13092564
AMA Style
Cai T, Palumbo F, Miacola C, Ceruti C, Rizzo M, Liguori G, Gallelli L, Palmieri A on behalf of the Italian Society of Andrology (SIA).
Icarifil® in Association with Daily Use of Tadalafil (5 mg) versus Standard Tadalafil Daily Dose (5 mg) or Alone: Results from a Controlled, Randomized Clinical Trial. Journal of Clinical Medicine. 2024; 13(9):2564.
https://doi.org/10.3390/jcm13092564
Chicago/Turabian Style
Cai, Tommaso, Fabrizio Palumbo, Carlos Miacola, Carlo Ceruti, Michele Rizzo, Giovanni Liguori, Luca Gallelli, and Alessandro Palmieri on behalf of the Italian Society of Andrology (SIA).
2024. "Icarifil® in Association with Daily Use of Tadalafil (5 mg) versus Standard Tadalafil Daily Dose (5 mg) or Alone: Results from a Controlled, Randomized Clinical Trial" Journal of Clinical Medicine 13, no. 9: 2564.
https://doi.org/10.3390/jcm13092564
APA Style
Cai, T., Palumbo, F., Miacola, C., Ceruti, C., Rizzo, M., Liguori, G., Gallelli, L., & Palmieri, A., on behalf of the Italian Society of Andrology (SIA).
(2024). Icarifil® in Association with Daily Use of Tadalafil (5 mg) versus Standard Tadalafil Daily Dose (5 mg) or Alone: Results from a Controlled, Randomized Clinical Trial. Journal of Clinical Medicine, 13(9), 2564.
https://doi.org/10.3390/jcm13092564
